L-asparaginase II of Escherichia Coli. Studies on the Enzymatic Mechanism of Action
Overview
Authors
Affiliations
Improving the Treatment of Acute Lymphoblastic Leukemia.
Radadiya A, Zhu W, Coricello A, Alcaro S, Richards N Biochemistry. 2020; 59(35):3193-3200.
PMID: 32786406 PMC: 7497903. DOI: 10.1021/acs.biochem.0c00354.
What makes a good new therapeutic L-asparaginase?.
Beckett A, Gervais D World J Microbiol Biotechnol. 2019; 35(10):152.
PMID: 31552479 DOI: 10.1007/s11274-019-2731-9.
Experimental Data in Support of a Direct Displacement Mechanism for Type I/II L-Asparaginases.
Schalk A, Antansijevic A, Caffrey M, Lavie A J Biol Chem. 2016; 291(10):5088-100.
PMID: 26733195 PMC: 4777844. DOI: 10.1074/jbc.M115.699884.
Montero D, Orellana P, Gutierrez D, Araya D, Salazar J, Prado V Infect Immun. 2014; 82(11):4767-77.
PMID: 25156722 PMC: 4249345. DOI: 10.1128/IAI.02030-14.
Crystal structure and allosteric regulation of the cytoplasmic Escherichia coli L-asparaginase I.
Yun M, Nourse A, White S, Rock C, Heath R J Mol Biol. 2007; 369(3):794-811.
PMID: 17451745 PMC: 1991333. DOI: 10.1016/j.jmb.2007.03.061.